NCT02794844View on ClinicalTrials.gov

Implementation of PPI Medication PGX Testing

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 21, 2016

Primary Completion Date

January 23, 2017

Study Completion Date

August 31, 2018

Conditions
Gastroesophageal Reflux
Interventions
DRUG

Genotype Guided PPI Dosing

Dosing of PPIs such as Prevacid and Nexium will be recommended based on CYP2C19 genotype information.

Trial Locations (1)

32827

Nemours Children's Hospital, Orlando

All Listed Sponsors
lead

Nemours Children's Clinic

OTHER

NCT02794844 - Implementation of PPI Medication PGX Testing | Biotech Hunter | Biotech Hunter